Moleculin Biotech Inc. (MBRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Moleculin Biotech Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$8.74
−5.61% today
Market cap
$10M
Overall quality
—
Kronos AI 30-day
+17.2%
5 of 8 simulated paths end higher
Moleculin Biotech Inc. (MBRX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $10M. It trades at $8.74, down 5.61% today. 3 analysts' average target of $240.00 implies +2646.0% from today's price. Kronos AI's 30-day forecast is +17.2% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $240.00 |
| Low – high | $40.00 – $620.00 |
| Analysts | 3 |
| Upside to average | +2646.0% |
Kronos AI 30-day forecast
| Expected close | $10.86 (+17.2%) |
| Likely range | −25.5% … +72.8% |
| As of | 2026-10-27 |
5 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.